Patents by Inventor Catherine Raffin

Catherine Raffin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7829588
    Abstract: Novel compounds that are modulators of PPAR-type receptors having the structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and in the field of cardiovascular diseases, immune diseases and/or diseases linked to the metabolism of lipids), or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: June 12, 2006
    Date of Patent: November 9, 2010
    Assignee: Galderma Research & Development
    Inventors: Philippe Diaz, Catherine Raffin
  • Patent number: 7592478
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: September 22, 2009
    Assignee: Galderma Research & Development
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Publication number: 20080213347
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Application
    Filed: October 30, 2007
    Publication date: September 4, 2008
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Patent number: 7348449
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: March 25, 2008
    Assignee: Galderma Research & Development
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti
  • Publication number: 20070054907
    Abstract: Novel compounds that are modulators of PPAR-type receptors having the structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and in the field of cardiovascular diseases, immune diseases and/or diseases linked to the metabolism of lipids), or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: June 12, 2006
    Publication date: March 8, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Philippe Diaz, Catherine Raffin
  • Publication number: 20050234131
    Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (1): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):
    Type: Application
    Filed: April 28, 2005
    Publication date: October 20, 2005
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Catherine Raffin, Thibaud Biadatti